Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (US20160161503) Diagnostic method for inflammatory bowel disease

Office : United States of America
Application Number: 14900867 Application Date: 27.06.2014
Publication Number: 20160161503 Publication Date: 09.06.2016
Grant Number: 09797912 Grant Date: 24.10.2017
Publication Kind : B2
Prior PCT appl.: Application Number:PCTAU2014000682 ; Publication Number: Click to see the data
IPC:
G01N 33/68
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68
involving proteins, peptides or amino acids
Applicants: NEWSOUTH INNOVATIONS PTY LIMITED
SYDNEY LOCAL HEALTH DISTRICT
Inventors: Valerie Christine Wasinger
Rupert Wing-Loong Leong
Agents: Ballard Spahr LLP
Priority Data: 2013902409 28.06.2013 AU
Title: (EN) Diagnostic method for inflammatory bowel disease
Abstract: front page image
(EN)

The invention relates to a method of diagnosing or assessing an inflammatory bowel disease in a subject, comprising comparing the level of one or more markers in a tissue or body fluid of the subject relative to a reference value for the one or more markers, wherein the marker is selected from the group consisting of Secretogranin-1 or a fragment thereof, guanylin or a fragment thereof, SPP 24 or a fragment thereof, AMBP or a fragment thereof; and serglycin or a fragment thereof.


Also published as:
WO/2014/205507